HPTN Publications

Fogel JM, Hudelson SE, Ou SS, Hart S, Wallis C, Morgado MG, Saravanan S, Tripathy S, Hovind L, Piwowar-Manning E, Sabin D, McCauley M, Gamble T, Zhang XC, Eron JJ, Gallant JE, Kumwenda J, Makhema J, Kumarasamy N, Chariyalertsak S, Hakim J, Badal-Faesen S, Akelo V, Hosseinipour MC, Santos BR, Godbole SV, Pilotto JH, Grinsztejn B, Panchia R, Mayer KH, Chen YQ, Cohen MS, Eshleman SH . HIV drug resistance in adults failing early antiretroviral treatment: results from the HIV Prevention Trials Network 052 trial. 2016, 72: 304-9
Fogel JM, Mwatha A, Richardson P, Brown ER, Chipato T, Alexandre M, Moodley D, Elbireer A, Mirochnick M, George K, Mofenson LM, Zwerski S, Coovadia HM, Eshleman SH . Impact of Maternal and Infant Antiretroviral Drug Regimens on Drug Resistance in HIV-Infected Breastfeeding Infants. Pediatr Infect Dis J. 2013, 32: e164-9
Fogel JM, Piwowar-Manning E, Debevec B, Walsky T, Schlusser K, Laeyendecker O, Wilson EA, McCauley M, Gamble T, Tegha G, Soko D, Kumwenda J, Hosseinipour MC, Chen YQ, Cohen MS, Eshleman SH . Impact of early antiretroviral therapy on the performance of HIV rapid tests and HIV incidence assays. J Acquir Immune Defic Syndr. 2017, 75: 426-430
Fogel JM, Piwowar-Manning E, Donohue K, Cummings V, Marzinke MA, Clarke W, Breaud A, Fiamma A, Donnell D, Kulich M, Mbwambo JK, Richter L, Gray G, Sweat M, Coates TJ, Eshleman SH . Determination of HIV Status in African Adults With Discordant HIV Rapid Tests. J Acquir Immune Defic Syndr. 2015, 69: 430-8
Fogel JM, Sandfort T, Zhang Y, Guo X, Clarke W, Breaud A, Cummings V, Hamilton EL, Ogendo A, Kayange N, Panchia R, Dominguez K, Chen YQ, Eshleman SH . Accuracy of Self-Reported HIV Status Among African Men and Transgender Women Who Have Sex with Men Who were Screened for Participation in a Research Study: HPTN 075. AIDS Behav. 2019, 23: 289-294
Fogel JM, Sivay MV, Cummings V, Wilson EA, Hart S, Gamble T, Laeyendecker O, Fernandez RE, Del Rio C, Batey D S, Mayer KH, Farley JE, McKinstry L, Hughes JP, Remien RH, Beyrer C, Eshleman SH . HIV Drug Resistance in a Cohort of HIV-Infected Men Who Have Sex with Men in the United States. AIDS. 2019
Fogel JM, Sivay MV, Cummings V, Wilson EA, Hart S, Gamble T, Laeyendecker O, Fernandez RE, Del Rio C, Batey DS, Mayer KH, Farley JE, McKinstry L, Hughes JP, Remien RH, Beyrer C, Eshleman SH . HIV Drug Resistance in a Cohort of HIV-infected MSM in the United States [HPTN 078]. AIDS. 2020, 34: 91-101
Fogel JM, Taha TE, Sun J, Hoover DR, Parsons TL, Kumwenda JJ, Mofenson LM, Fowler MG, Hendrix CW, Kumwenda NI, Eshleman SH, Mirochnick M . Stavudine concentrations in women receiving postpartum antiretroviral treatment and their breastfeeding infants. J Acquir Immune Defic Syndr. 2012, 60: 462-5
Fogel JM, Wang L, Parsons TL, Ou SS, Piwowar-Manning E, Chen Y, Mudhune VO, Hosseinipour MC, Kumwenda J, Hakim JG, Chariyalertsak S, Panchia R, Kumarasamy N, Grinsztejn B, Makhema J, Pilotto J, Santos BR, Mayer KH, McCauley M, Gamble T, et. Al, Bumpus N, Hendrix C, Cohen M, Eshleman S . Undisclosed antiretroviral drug use in a multinational clinical trial (HIV Prevention Trials Network 052). J Infect Dis. 2013, 208: 1624-8
Fogel JM, Zhang Y, Palumbo PJ, Guo X, Clarke W, Breaud A, Richardson P, Piwowar-Manning E, Hamilton EL, Ha TV, Dumchev K, Djoerban Z, Hoffman I, Hanscom B, Miller WC, Eshleman SH . Use of Antiretroviral Drug Testing to Assess the Accuracy of Self-reported Data from HIV-Infected People Who Inject Drugs. AIDS Behav.
Fogel JM, Zhang Y, Palumbo PJ, Guo X, Richardson P, Clarke W, Breaud A, Piwowar-Manning E, Hamilton EL, Ha TV, Dumchev K, Djoerban Z, Hoffman I, Hanscom B, Miller WC, Eshleman SH . Use of Antiretroviral Drug Testing to Assess the Accuracy of Self-Reported Data from Hiv-Infected People Who Inject Drugs [HPTN 074]. AIDS Behav. 2019, 23: 2101–2108
Fouda GG, Yates NL, Pollara J, Shen X, Overman GR, Mahlokozera T, Wilks AB, Kang HH, Salazar-Gonzalez JF, Salazar MG, Kalilani L, Meshnick SR, Hahn BH, Shaw GM, Lovingood RV, Denny TN, Haynes B, Letvin NL, Ferrari G, Montefiori DC, Tomaras GD, Permar SR . HIV-specific functional antibody responses in breast milk mirror those in plasma and are primarily mediated by IgG antibodies. J of Virol. 2011, 85: 9555-67
Fowler MG, Coovadia H, Herron CM, Maldonado Y, Chipato T, Moodley D, Musoke P, Aizire J, Manji K, Stranix-Chibanda L, Fawzi W, Chetty V, Msweli L, Kisenge R, Brown E, Mwatha A, Eshleman SH, Richardson P, Allen M, George K, Andrew P, et.al, Zwerski S, Mofenson LM, Jackson JB, HPTN 046 Protocol Team . Efficacy and Safety of an Extended Nevirapine Regimen in Infants of Breastfeeding Mothers With HIV-1 Infection for Prevention of HIV-1 Transmission (HPTN 046): 18-Month Results of a Randomized, Double-Blind, Placebo-Controlled Trial. J Acquir Immune Defic Syndr. 2014, 65: 366-74
Franks J, Hirsch-Moverman Y, Loquere AS, Amico KR, Grant RM, Stirratt M, Dye BJ, Rivera Y, Gamboa R, Mannheimer SB . Sex, PrEP, and Stigma: Experiences with HIV Pre-exposure Prophylaxis Among New York City MSM Participating in the HPTN 067/ADAPT Study. AIDS and Behavior. 2018, 22: 1139-1149
Frew PM, Parker K, Vo L, Haley D, O'Leary A, Diallo DD, Golin CE, Kuo I, Soto-Torres L, Wang J, Adimora AA, Randall LA, del Rio C, Hodder S, for the HPTN 064 Study Team . Socioecological factors influencing women's HIV risk in the United States: qualitative findings from the women's HIV SeroIncidence study (HPTN 064). BMC Public Health. 2016, 16: 803
Fuchs J, Celum C, Wang J, Hughes J, Sanchez J, Cowan F, Reid S, Delany-Moretlwe S, Corey L, Wald A; HIV Prevention Trials Network 039 Protocol Team . Clinical and virologic efficacy of herpes simplex virus type 2 suppression by acyclovir in a multicontinent clinical trial. J Infect Dis. 2010, 201: 1164-8
Gadkari DA, Quinn TC, Mehendale SM, Gangakhedkar RR, Divekar AD, Risbud AR, Chan-Tack K, Shepherd M, Gaydos C, Bollinger RC . HIV-1 DNA Shedding in Genital Ulcers and its Asscociated Risk Factors in Pune, India. J Acquir Immune Defic Syndr Hum Retrovirol. 1998, 18: 277-281
Gamiel JL, Tobian AA, Laeyendecker OB, Reynolds SJ, Ashley-Morrow R, Swerwadda D, Gray RH, and Quinn TC . Improved performance of enzyme linked immunosorbent assays and the effect of human immunodeficiency virus co-infection on the serologic detection of herpes simplex virus type-2 in Rakai Uganda. Clin Vaccine Immunol. 2008, 15: 888-890
Ganzura L, Latif A, Bassett M, Machekano R, Katzenstein DA, Mason PR . Syphilis serology and HIV infection in Harare, Zimbabwe. Sex Transm Infect. 1999, 75: 426-30
Gaydos C, Hardick J . Point of care diagnostics for sexually transmitted infections: perspectives and advances. Expert Rev Anti Infect Ther. 2014, 12: 657-72
Gaydos C, Maldeis NE, Hardick A, Hardick J, Quinn TC . Mycoplasma genitalium as a contributor to the multiple etiologies of cervicitis in women attending sexually transmitted disease clinics. Sex Transm Dis. 2009, 36: 598-606
Gaydos CA, Barnes M, Aumakhan B, Quinn N, Wright C, Agreda P, Whittle P, and Hogan T . Chlamydia trachomatis age-specific prevalence in women who used an internet-based self-screening program compared to women who were screened in family planning clinics. Sex Transm Dis. 2011, 38: 74-8
Gaydos CA, Crotchfelt KA, Shah N, Tennant M, Quinn TC, Gaydos JC, McKee KT, Rompalo AM . Evaluation of dry and wet transported intravaginal swabs to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections by PCR in female soldiers. J Clin Microbiol. 2002, 40: 758-61
Gaydos CA, Farshy C, Barnes M, Quinn N, Agreda P, Rivers CA, Schwebke J, Papp J . Can mailed swab samples be dry-shipped for the detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis by nucleic acid amplification tests?. Diag Microbiol Infect Dis. 2012, 73: 16-20
Gaydos CA, Hsieh Y-H, Barnes M, Quinn N, Agreda P, Jett-Goheen M, Whittle P, Hogan T . Trichomonas vaginalis infection in women who submit self-collected vaginal samples after internet recruitment. Sex Transm Dis. 2011, 38: 828-32
Gaydos CA, Klausner JD, Pai NP, Kelly H, Coltart C, Peeling RW . Rapid and point-of-care tests for the diagnosis of Trichomonas vaginalis in women and men. Sex Transm Inf. 2017, 93: S31-S35
Gaydos CA, Rizzo-Price P, Balakrishnan P, Mateta SR, Leon S, Yin Y-P, Quinn TC, Strader LC, Pequegnat W . For the NIMH Collaborative HIV/STD Prevention Trial Group. Impact of international laboratory partnerships on the performance of HIV/STD testing in five resource constrained countries. Int J STD AIDS. 2011, 22: 645-52
Gaydos CA, Schwebke J, Dombrowski J, Marrazzo J, Coleman J, Silver B, Barnes M, Crane L, Fine P . Clinical performance of the Solana(R) Point-of-Care Trichomonas Assay from clinician-collected vaginal swabs and urine specimens from symptomatic and asymptomatic women. Expert Rev Mol Diagn. 2017, 17: 303-306
Gaydos CA, Wright C, Wood BJ, Waterfield G, Hobson S and Quinn TC . Chlamydia trachomatis reinfection rates amoung female adolescents seeking rescreening in school-based health centers. Sex Transmit Dis. 2008, 35: 233-7
Gaydos, CA, Quinn TC, Willis D, Weissfeld A, Hook EW, Martin DH, Ferrero, Schachter J . Performance of the APTIMA Combo 2 assay for the multiplex detection of Chlamydia trachomatis and Neisseria gonorrheae in female urine and endocervical swab specimens. J Clin Microbiol. 2003, 41: 304-9
Genberg BL, Hlavka Z, Konda KA, Maman S, Chariyalertsak S, Chingono A, Mbwambo J, Modiba P, Van Rooyen H, Celentano DD . A comparison of HIV/AIDS-related stigma in four countries: negative attitudes and perceived acts of discrimination towards people living with HIV/AIDS. Soc Sci Med. 2009, 68: 2279-87 PMID:19427086
Genberg BL, Kawichai S, Chingono A, Sendah M, Chariyalertsak S, Konda KA, Celentano DD . Assessing HIV/AIDS Stigma and Discrimination in Developing Countries. AIDS Behav. 2008, 12: 772-80
Genberg BL, Kulich M, Kawichai S, Modiba P, Chingono A, Kilonzo GP, Richter L, Pettifor A, Sweat M, Celentano DD; NIMH Project Accept Study Team (HPTN 043) . HIV Risk Behaviors in Sub-Saharan Africa and Northern Thailand: Baseline Behavioral Data From Project Accept. JAIDS. 2008, 49: 309-19.
Gilbert PB, Juraska M, deCamp AC, Karuna S, Edupuganti S, Mgodi N, Donnell DJ, Bentley C, Sista N, Andrew P, Isaacs A, Huang Y, Zhang L, Capparelli E, Kochar N, Wang J, Eshleman SH, Mayer KH, Margaret CA, Hural J, Kublin JG, Gray G, Montefiori DC, Gomez MM, Burns DN, McElrath J, Ledgerwood J, Graham BS, Mascola JR, Cohen M, Corey L . Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials. Stat Commun Infect Dis. 2017, 9
Giovenco D, Kahn K, Hughes JP, MacPhail C, Wagner R, Pettifor A . Self-Esteem as an Indicator of Transactional Sex Among Young Women in Rural South Africa (HPTN 068). AIDS Behav.
Go VF, Hershow RB, Kiriazova T, Sarasvita R, Bui Q, Latkin CA, Rose S, Hamilton E, Lancaster KE, Metzger D, Hoffman IF, Miller WC . Client and Provider Perspectives on Antiretroviral Treatment Uptake and Adherence Among People Who Inject Drugs in Indonesia, Ukraine and Vietnam: HPTN 074. AIDS Behav. 2019, 23: 1084-1093
Godbole S, Ghate M . Issues in managing and coordinating clinical research in India. Research Practitioner. 2006, 7: 219-20
Goin DE, Pearson RM, Craske MG, Stein A, Pettifor A, Lippman SA, Kahn K, Neilands TB, Hamilton EL, Selin A, MacPhail C, Wagner RG, Gomez-Olive FX, Twine R, Hughes JP, Agyei Y, Laeyendecker O, Tollman S, Ahern J . Depression and Incident HIV in Adolescent Girls and Young Women in HPTN 068: Targets for Prevention and Mediating Factors. Am J Epidemiol. 2019
Goldenberg RL, Andrews WW, Hoffman I, Fawzi W, Valentine M, Young A, Read JS, Brown ER, Mudenda V, Kafulafula G, Mwinga K, Taha TE . Fetal Fibronectin and Adverse Pregnancy Outcomes in a Predominantly HIV-infected African Population. Obstet Gynecol. 2007, 109: 392-401 PMID: 17267841
Goldenberg RL, Mudenda V, Read JS, Brown ER, Sinkala M, Kamiza S, Martinson F, Kaaya E, Hoffman I, Fawzi W, Valentine M, Taha TE; HPTN 024 Study Team . Histologic Chorioamnionitis, Antibiotics and Adverse Infant Outcomes in a Predominantly HIV-1-Infected African Population. Am J Obstet Gynecol. 2006, 195: 1065-74 PMID: 16875654
Goldenberg RL, Mwatha A, Read JS, Adeniyi-Jones S, Sinkala M, Msmanga G, Martinson F, Hoffman I, Fawzi W, Valentine M, Emel L, Brown E, Mudenda V, Taha TE; HPTN024 Team . The HPTN 024 Study: the efficacy of antibiotics to prevent chorioamnionitis and preterm birth. Am J Obstet Gynecol. 2006, 194: 650-61 PMID:16522393
Golin CE, Haley DF, Wang J, Hughes JP, Kuo I, Justman J, Adimora AA, Soto-Torres L, O'Leary A, Hodder S . Post-traumatic Stress Disorder Symptoms and Mental Health over Time among Low-Income Women at Increased Risk of HIV in the U.S.. J Health Care Poor Underserved. 2016, 27: 891-910
Golub SA, Rosenthal L, Cohen DE and Mayer KH . Determinants of High-Risk Sexual Behavior During Post-Exposure Prophylaxis to Prevent HIV Infection. AIDS Behav. 2008, 12: 852-9 PMID:17682938
Gorbach PM, Kelly CW, Borgerding JA, Ramjee G, Tembo T, Kumwenda N, Musara P, Roberts S, Maslankowski L . Effects of partnership change on microbicide gel adherence in a clinical trial (HPTN 035). AIDS Behav. 2014, 18: 855-61
Gorbach PM, Mensch BS, Husnik M, Coly A, Mâsse B, Makanani B, Nkhoma C, Chinula L, Tembo T, Mierzwa S, Reynolds K, Hurst S, Coletti A, Forsyth A . Effect of computer-assisted interviewing on self-reported sexual behavior data in a microbicide clinical trial. AIDS Behav. 2013, 17: 790-800
Goulder PJ, Tang Y, Brander C, Betts M, Altfeld M, Annamalai K, Trocha A, He S, Rosenberg E, Ogg G, O’Callaghan CA, Kalams SA, McKinney, Jr. RE, Mayer K, Koup RA, Pelton SI, Burchett SK, McIntosh K, Walker BD . Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children. J Exp Med. 2000, 192: 1819-32
Grabowski MK, Reynolds SJ, Kagaayi J, Gray RH, Clarke W, Chang LW, Nakigozi G, Laeyendecker O, Redd AD, Billioux V, Ssekubugu R, Nalugoda F, Wawer MJ, Serwadda D, Quinn TC, Tobian AAR . The validity of self-reported antiretroviral use in persons living with HIV: a population-based study. AIDS. 2018, 32: 363-369
Grant RM, Mannheimer S, Hughes JP, Hirsch-Moverman Y, Loquere A, Chitwarakorn A, Curlin ME, Li M, Amico KR, Hendrix C, Anderson PL, Dye BJ, Piwowar-Manning E, McKinstry L, Elharrar V, Stirratt M, Rooney JF, Eshleman SH, Griensven F, Holtz T .
Greer AE, Ou SS, Wilson E, Piwowar-Manning E, Forman MS, McCauley M, Gamble T, Ruangyuttikarn C, Hosseinipour MC, Kumarasamy N, Nyirenda M, Grinsztejn B, Pilotto JH, Kosashunhanan N, Goncalves de Melo M, Makhema J, Akelo V, Panchia R, Badal-Faesen S, Chen YQ, Cohen MS, Eshleman SH, Thio CL, Valsamakis A . Comparison of Hepatitis B Virus Infection in HIV-Infected and HIV-Uninfected Participants Enrolled in a Multinational Clinical Trial: HPTN 052. J Acquir Immune Defic Syndr. 2017, 76: 388-393
Gregory Phillips 2nd, Brian A Feinstein, Matthew Levy, Irene Kuo, Sarah N. Glick, Sheldon D. Fields, Typhanye V. Dyer, Dylan Felt, Manya Magnus . Changes in Sexual and Gender Identity and Their Associations with Internalized Homophobia Among Black Men Who have Sex with Men in the HPTN 061 BROTHERS Cohort. 2020
Gregson S, Machekano R, Donnelly CA, Mbizvo MT, Anderson RM, Katzenstein DA . Estimating HIV incidence from age-specific prevalence data: comparison of concurrent cohort estimates in a study of male factory workers, Harare, Zimbabwe. AIDS. 1998, 12: 2049-58
Grinsztejn B, Hosseinipour MC, Ribaudo HJ, Swindells S, Eron J, Chen YQ, Wang L, Ou SS, Anderson M, McCauley M, Gamble T, Kumarasamy N, Hakim JG, Kumwenda J, Pilotto JH, Godbole SV, Chariyalertsak S, et.al, de Melo MG, Mayer KH, Eshleman SH, Piwowar-Manning E, Makhema J, Mills LA, Panchia R, Sanne I, Gallant J, Hoffman I, Taha TE, Nielsen-Saines K, Celentano D, Essex M, Havlir D, Cohen MS, HPTN 052-ACTG Study Team . Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial. Lancet Infect Dis. 2014, 14: 281-90
Gross M, Buchbinder SP, Celum C, Heagerty P, Seage GR, 3rd . Rectal microbicides for U.S. gay men. Are clinical trials needed? Are they feasible? HIVNET Vaccine Preparedness Study Protocol Team.. Sex Transm Dis. 1998, 25: 296-302
Gross M, Buchbinder SP, Holte S, Celum CL, Koblin BA, Douglas JM, Jr . Use of reality female condoms for anal sex by US men who have sex with men. HIVNET Vaccine Preparedness Study Protocol Team. Am J Public Health. 1999, 89: 1739-41
Gross M, Celum CL, Tabet SR, Kelly CW, Coletti AS, Chesney MA . Acceptability of a bioadhesive nonoxynol-9 gel delivered by an applicator as a rectal microbicide. Sex Transm Dis. 1999, 26: 572-578
Gross M, Holte S, Seage GR 3rd, Buchbinder SP, Metzger DS, Mayer KH . Feasibility of chemoprophylaxis studies in high risk HIV-seronegative populations. AIDS Educ Prev. 2000, 12: 71-8
Gross M, Holte SE, Marmor M, Mwatha A, Koblin BA, Mayer KH . Anal sex among HIV-seronegative women at high risk of HIV exposure. The HIVNET Vaccine Preparedness Study 2 Protocol Team. J Acquir Immune Defic Syndr. 2000, 24: 393-8
Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C, Sherman J, Bakaki P, Ducar C, Deseyve M, Emel L, Mirochnick M, Fowler MG, Mofenson L, Miotti P, Dransfield K, Bray D, Mmiro F, Jackson JB . Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet. 1999, 354: 795-802
Guffey MB, Richardson B, Husnik M, Makanani B, Chilongozi D, Yu E, Ramjee G, Mgodi N, Gomez K, Hillier SL, Karim SA; HIV Prevention Trials Network (HPTN) 035 Study Team, Karim SA, HIV Prevention Trials Network (HPTN) 035 Study Team . HPTN 035 phase II/IIb randomised safety and effectiveness study of the vaginal microbicides BufferGel and 0.5% PRO 2000 for the prevention of sexually transmitted infections in women. Sex Transm Infect. 2014, 90: 363-9
Gulick RM, Wilkin TJ, Chen YQ, Landovitz RJ, Amico KR, Young AM, Richardson P, Marzinke MA, Hendrix CW, Eshleman SH, McGowan I, Cottle LM, Andrade A, Marcus C, Klingman KL, Chege W, Rinehart AR, Rooney JF, Andrew P, Salata RA, Magnus M, Farley JE, Liu A, Frank I, Ho K, Santana J, Stekler JD, McCauley M, Mayer KH . Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305). J Infect Dis. 2017, 215: 238-246
Gulick RM, Wilkin TJ, Chen YQ, Landovitz RJ, Amico KR, Young AM, Richardson P, Marzinke MA, Hendrix CW, Eshleman SH, McGowan I, Cottle LM, Andrade A, Marcus C, Klingman KL, Chege W, Rinehart AR, Rooney JF, Andrew P, Salata RA, Siegel M, Manabe YC, Frank I, Ho K, Santana J, Stekler JD, Swaminathan S, McCauley M, Hodder S, Mayer KH . Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Women: A Phase 2 Randomized Trial. Ann Intern Med. 2017, 167: 384-393
Gupta A, Saple DG, Nadkarni G, Shah B, Vaidya S, Hingankar N, Chaturbhuj D, Deshmukh P, Walshe L, Hudelson SE, James M, Paranjape RS, Eshleman SH, Tripathy S . One-, two-, and three-class resistance among HIV-infected patients on antiretroviral therapy in private care clinics: Mumbai, India. AIDS Res Hum Retroviruses. 2010, 26: 25-31
Gwanzura L, McFarland W, Alexander, Burke RL, Katzenstein DA . Association between human immunodeficiency virus and herpes simplex virus type 2 seropositivity among male factory workers in Zimbabwe. J Infect Dis. 1998, 177: 481-4
Haley DF, Golin C, El-Sadr W, Hughes JP, Wang J, Roman Isler M, Mannheimer S, Kuo I, Lucas J, DiNenno E, Justman J, Frew PM, Emel L, Rompalo A, Polk S, Adimora AA, Rodriquez L, Soto-Torres L, Hodder S . Venue-based recruitment of women at elevated risk for HIV: an HIV Prevention Trials Network study. J Womens Health (Larchmt). 2014, 23: 541-51
Haley DF, Justman JE . The HIV epidemic among women in the United States: a persistent puzzle. J Womens Health. 2013, 22: 715-7
Haley DF, Lucas J, Golin CE, Wang J, Hughes JP, Emel LM, El-Sadr W, Frew PM, Justman J, Adimora AA, Watson CC, Mannheimer S, Rompalo A, Soto-Torres L, Tims-Cook Z, Carter Y, Hodder SL, HPTN 064 Study Team . Retention Strategies and Factors Associated with Missed Visits Among Low Income Women at Increased Risk of HIV Acquisition in the US (HPTN 064. AIDS Patient CARE STDS. 2014, 28: 206-17
Hall G, Li K, Wilton L, Wheeler D, Fogel J, Wang L, Koblin B, Fogel J . A Comparison of Referred Sexual Partners to Their Community Recruited Counterparts in The BROTHERS Project (HPTN 061). AIDS and Behavior. 2015, 19: 2214-23
Hall, G. C., Young, A., Krakauer, C., Watson, C. C., Cummings, V., Mayer, K., Koblin, B. . Sexual Risk Behaviors Among Black Men Who Have Sex With Men Who Also Report Having Sex With Transgender Partners: Analysis of HIV Prevention Trials Network (HPTN) 061 Study.. AIDS Educ Prev. 2017, 29: 418-431
Halperin DT, Weiss HA, Hayes R, Auvert B, Bailey RC, Caldwell J, Coates T, Padian N, Potts M, Ronald A, Short R, Williams B, Klausner J . Response to Ronald Gray, Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda ( 2000, 14:2371-2381). AIDS. 2002, 16: 810-2
Halpern SD, Metzger DS, Berlin JA, Ubel PA . Who will enroll? Predicting participation in a phase II AIDS vaccine trial. J Acquir Immune Defic Syndr. 2001, 27: 281-8
Hanrahan D, Sexton P, Hui K, Teitcher J, Sugarman J, London AJ, Barnes M, Purpura J, Klitzman R . Linguistic and Cultural Challenges in Communication and Translation in US-Sponsored HIV Prevention Research in Emerging Economies. PLoS One. 2015, 10: e01333394
Harawa N, Wilton L, Wang L, Mao C, Kuo I, Penniman T, Shoptaw S, Griffith S, Williams JK, Cummings V, Mayer K, Koblin B; HPTN 061 Study Team, Koblin B, HPTN 061 Study Team . Types of Female Partners Reported by Black Men Who Have Sex with Men and Women (MSMW) and Associations with Intercourse Frequency, Unprotected Sex and HIV and STI Prevalence. AIDS Behav. 2014, 18: 1548-59
Hardick J, Crowell TA, Lombardi K, Akintunde A, Odeyemi S, Ivo A, Eluwa G, Njab J, Baral SD, Nowak RG, Quinn TC, Barbian K, Anzick S, Adebajo S, Charurat ME, Ake J, Gaydos CA . Molecular screening for Neisseria gonorrhoeae antimicrobial resistance markers in Nigerian men who have sex with men and transgender women. Int J STD AIDS. 2018, 29: 1273-1281
Hargreaves JR, Krishnaratne S, Mathema H, LillestonPS, Sievwright K, Mandla N, Mainga T, Vermaak R, Schaap A, Donnell D, Ayles H, Hayes RJ, Hoddinott G, Bond V, Stangl A, on behalf of the HPTN 071 (PopART) Study Team . Individual and community-level risk factors for HIV stigma in 21 Zambian and South African communities: analysis of data from the HPTN 071 (PopART) study. AIDS. 2018, 32: 783-793
Hargreaves JR, Stangl A, Bond V, Hoddinott G, Krishnaratne S, Mathema H, Moyo M, Viljoen L, Brady L, Sievwright K, Horn L, Sabapathy K, Ayles H, Beyers N, Bock P, Fidler S, Griffith S, Seeley J, Hayes R, HPTN 071 Study Team . HIV-related stigma and universal testing and treatment for HIV prevention and care: design of an implementation science evaluation nested in the HPTN 071 (PopART) cluster-randomized trial in Zambia and South Africa. 2016
Harrison LH, do Lago RF, Friedman, RK, Rodrigues L, Santos EM, de Melo MF, Moulton LH, Schechter, M . Incident HIV Infection in a high- risk, homosexual male cohort in Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr. 1999, 21: 408-12
Hayes R, Ayles H, Beyers N, Sabapathy K, Floyd S, Shanaube K, Bock P, Griffith S, Moore A, Watson-Jones D, Fraser C, Vermund SH, Fidler S; HPTN 071 (PopART) Study Team, Fidler S, HPTN 071 (PopART) Study Team . HPTN 071 (PopART): Rationale and design of a cluster-randomised trial of the population impact of an HIV combination prevention intervention including universal testing and treatment – a study protocol for a cluster randomised trial. Trials. 2014, 15: 57
Hayes R, Fidler S, Cori A, Fraser C, Floyd S, Ayles H, Beyers N, El-Sadr W; HPTN 071 (PopART) Study Team, El-Sadr W, HPTN 071 (PopART) Study Team . HIV Treatment-As-Prevention Research: Taking the Right Road at the Crossroads. PLoS Med. 2015, 12
Hayes R, Floyd S, Schaap A, Shanaube K, Bock P, Sabapathy K, Griffith S, Donnell D, Piwowar-Manning E, El-Sadr W, Beyers N, Ayles H, Fidler S, HPTN 071 (PopART) Study Team . A universal testing and treatment intervention to improve HIV control: One-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial. PLoS Med. 2017, 14: e1002292
Hayes R, Sabapathy K, Fidler S . Universal testing and treatment as an HIV prevention strategy: research questions and methods. Curr HIV Res. 2011, 9: 429-45
Hayes RJ, Donnell D, Floyd S, Mandla N, Bwalya J, Sabapathy K, Yang B, Phiri M, Schaap A, Eshleman SH, Piwowar-Manning E, Kosloff B, James A, Skalland T, Wilson E, Emel L, Macleod D, Dunbar R, Simwinga M, Makola N, Bond V, Hoddinott G, Moore A, Griffith S, Deshman Sista N, Vermund SH, El-Sadr W, Burns DN, Hargreaves JR, Hauck K, Fraser C, Shanaube K, Bock P, Beyers N, Ayles H, Fidler S, HPTN 071 (PopART) Study Team . Effect of Universal Testing and Treatment on HIV Incidence - HPTN 071 (PopART). N Engl J Med. 2019, 381: 207-218
Hendriksen ES, Hlubinka D, Chariyalertsak S, Chingono A, Gray G, Mbwambo J, Richter L, Kulich M, Coates TJ . Keep Talking About It: HIV/AIDS-Related Communication and Prior HIV Testing in Tanzania, Zimbabwe, South Africa, and Thailand. AIDS Behav. 2009, 13: 1213-21
Hendrix CW, Andrade A, Bumpus NN, Kashuba AD, Marzinke MA, Moore A, Anderson PL, Bushman LR, Fuchs EJ, Wiggins I, Radebaugh C, Prince HA, Bakshi RP, Wang R, Richardson P, Shieh E, McKinstry L, Li X, Donnell D, Elharrar V, Mayer KH, Patterson KB . Dose Frequency Ranging Pharmacokinetic Study of Tenofovir-Emtricitabine After Directly Observed Dosing in Healthy Volunteers to Establish Adherence Benchmarks (HPTN 066). AIDS Res Hum Retroviruses. 2016, 32: 32-43
Hendrix CW, Cao YJ, Fuchs EJ . Topical microbicides to prevent HIV: clinical drug development challenges. Annu Rev Pharmacol Toxicol. 2009, 49: 349-75 PMID:19006450
Hermanstyne KA, Green HD Jr., Cook R, Tieu HV, Dyer TV, Hucks-Ortiz C, Wilton L, Latkin C, Shoptaw S . Social Network Support and Decreased Risk of Seroconversion in Black MSM: Results of the BROTHERS (HPTN 061) Study. J Acquir Immune Defic Syndr. 2018, 78: 163-168
Hickson, D. A., Mena, L. A., Wilton, L., Tieu, H. V., Koblin, B. A., Cummings, V., Latkin, C., Mayer, K. H. . Sexual Networks, Dyadic Characteristics, and HIV Acquisition and Transmission Behaviors Among Black Men Who Have Sex With Men in 6 US Cities. Am J Epidemiol. 2017, 185: 786-800
Hightow-Weidman LB, Magnus M, Beauchamp G, Hurt CB, Shoptaw S, Emel L, Piwowar-Manning E, Mayer KH, Nelson LE, Wilton L, Watkins P, Whitfield D, Fields SD, Wheeler D . Incidence and Correlates of STIs among Black Men who have Sex with Men Participating in the HPTN 073 PrEP Study. Clin Infect Dis.
Hill LM, Abler L, Maman S, Twine R, Kahn K, MacPhail C, Pettifor A . Hope, the Household Environment, and Sexual Risk Behaviors Among Young Women in Rural South Africa (HPTN 068). AIDS Behav. 2018, 22: 1908-1918
Hill, M. J., Holt, M., Hanscom, B., Wang, Z., Cardenas-Turanzas, M., Latkin, C. . Gender and race as correlates of high risk sex behaviors among injection drug users at risk for HIV enrolled in the HPTN 037 study. Drug Alcohol Depend. 2018, 183: 267-274